[The specific features of coronary heart disease in patients with pulmonary tuberculosis]

Problemy Tuberkuleza I Boleznei Legkikh
|March 4, 2006
PubMed

Insights

Coronary heart disease (CHD) affects 8.4% of pulmonary tuberculosis patients, particularly elderly females. Clinical signs of CHD are more common in those with less active or residual tuberculosis.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Context:

  • Pulmonary tuberculosis (TB) is a significant global health issue.
  • Comorbidities like coronary heart disease (CHD) can complicate TB management.
  • Understanding the interplay between TB and CHD is crucial for patient care.

Purpose:

  • To investigate the prevalence and specific characteristics of coronary heart disease (CHD) in patients diagnosed with pulmonary tuberculosis.
  • To analyze the relationship between CHD prevalence and factors such as age, gender, and the nature of the tuberculous process.
  • To identify potential indicators of CHD in pulmonary tuberculosis patients, including electrocardiogram (ECG) changes.

Summary:

  • Coronary heart disease (CHD) was diagnosed in 8.4% (41 of 491) of patients with pulmonary tuberculosis.
  • CHD prevalence was higher in elderly and senile females. Clinical manifestations appeared at older ages in females compared to males.
  • Above 60 years, CHD prevalence in TB patients matched the general population. Less active or residual TB correlated with more frequent CHD clinical signs.

Impact:

  • This study highlights the increased risk of CHD in pulmonary tuberculosis patients, especially older females.
  • Findings suggest that ECG changes may indicate CHD even without prior diagnosis in TB patients.
  • Identifying CHD in TB patients can lead to timely interventions, improving patient outcomes and reducing comorbidity burden.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: